Search research articles
Contact Us
Filters
Showing results (401-410 of 434) with videos related to
Page
of 44
Sort By:
Dermatology and Therapy
|
June 10, 2019
Factors Influencing Sleep Difficulty and Sleep Quantity in the Citizen Pscientist Psoriatic Cohort
Mary Patricia Smith, Karen Ly, Quinn Thibodeaux, et al.
Journal of Psoriasis and Psoriatic Arthritis
|
August 22, 2017
National Psoriasis Foundation Priorities for Patient-Centered Research: Proceedings from the 2016 Conference
Ladan Afifi, Lindsey Shankle, April W Armstrong, et al.
The Journal of Clinical Investigation
|
June 14, 2016
RAC1 activation drives pathologic interactions between the epidermis and immune cells
Mårten C G Winge, Bungo Ohyama, Clara N Dey, et al.
Journal of Drugs in Dermatology : JDD
|
December 5, 2023
International Dermatology Outcome Measures (IDEOM) - Report from the 2022 Annual Meeting
Kathryn Lee, Michael J Woodbury, Melissa Peri Zundell, et al.
JAMA Dermatology
|
September 21, 2022
Association of Apremilast With Vascular Inflammation and Cardiometabolic Function in Patients With Psoriasis: The VIP-A Phase 4, Open-label, Nonrandomized Clinical Trial
Joel M Gelfand, Daniel B Shin, April W Armstrong, et al.
The Journal of Rheumatology
|
May 3, 2017
Proceedings of the GRAPPA 2016 Retreat
Deepak R Jadon, Dafna D Gladman, Philip J Mease, et al.
JAMA Dermatology
|
June 22, 2018
Dietary Recommendations for Adults With Psoriasis or Psoriatic Arthritis From the Medical Board of the National Psoriasis Foundation: A Systematic Review
Adam R Ford, Michael Siegel, Jerry Bagel, et al.
The Journal of Investigative Dermatology
|
February 24, 2020
A Randomized Placebo-Controlled Trial of Secukinumab on Aortic Vascular Inflammation in Moderate-to-Severe Plaque Psoriasis (VIP-S)
Joel M Gelfand, Daniel B Shin, Kristina Callis Duffin, et al.
The British Journal of Dermatology
|
July 3, 2026
Durability of Response to Icotrokinra in Adults With Moderate-to-Severe Plaque Psoriasis: One-Year Results From the Phase 3, Placebo- and Active Comparator-Controlled ICONIC-ADVANCE 1 & ICONIC-ADVANCE 2 Trials
Linda Stein Gold, April W Armstrong, Jennifer Soung, et al.
The New England Journal of Medicine
|
August 13, 2016
Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa
Alexa B Kimball, Martin M Okun, David A Williams, et al.
Page
of 44
Search research articles
Search
Showing results (401-410 of 434) with videos related to
Sort By:
Page
of 44
Dermatology and Therapy
|
June 10, 2019
Factors Influencing Sleep Difficulty and Sleep Quantity in the Citizen Pscientist Psoriatic Cohort
Mary Patricia Smith, Karen Ly, Quinn Thibodeaux, et al.
Journal of Psoriasis and Psoriatic Arthritis
|
August 22, 2017
National Psoriasis Foundation Priorities for Patient-Centered Research: Proceedings from the 2016 Conference
Ladan Afifi, Lindsey Shankle, April W Armstrong, et al.
The Journal of Clinical Investigation
|
June 14, 2016
RAC1 activation drives pathologic interactions between the epidermis and immune cells
Mårten C G Winge, Bungo Ohyama, Clara N Dey, et al.
Journal of Drugs in Dermatology : JDD
|
December 5, 2023
International Dermatology Outcome Measures (IDEOM) - Report from the 2022 Annual Meeting
Kathryn Lee, Michael J Woodbury, Melissa Peri Zundell, et al.
JAMA Dermatology
|
September 21, 2022
Association of Apremilast With Vascular Inflammation and Cardiometabolic Function in Patients With Psoriasis: The VIP-A Phase 4, Open-label, Nonrandomized Clinical Trial
Joel M Gelfand, Daniel B Shin, April W Armstrong, et al.
The Journal of Rheumatology
|
May 3, 2017
Proceedings of the GRAPPA 2016 Retreat
Deepak R Jadon, Dafna D Gladman, Philip J Mease, et al.
JAMA Dermatology
|
June 22, 2018
Dietary Recommendations for Adults With Psoriasis or Psoriatic Arthritis From the Medical Board of the National Psoriasis Foundation: A Systematic Review
Adam R Ford, Michael Siegel, Jerry Bagel, et al.
The Journal of Investigative Dermatology
|
February 24, 2020
A Randomized Placebo-Controlled Trial of Secukinumab on Aortic Vascular Inflammation in Moderate-to-Severe Plaque Psoriasis (VIP-S)
Joel M Gelfand, Daniel B Shin, Kristina Callis Duffin, et al.
The British Journal of Dermatology
|
July 3, 2026
Durability of Response to Icotrokinra in Adults With Moderate-to-Severe Plaque Psoriasis: One-Year Results From the Phase 3, Placebo- and Active Comparator-Controlled ICONIC-ADVANCE 1 & ICONIC-ADVANCE 2 Trials
Linda Stein Gold, April W Armstrong, Jennifer Soung, et al.
The New England Journal of Medicine
|
August 13, 2016
Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa
Alexa B Kimball, Martin M Okun, David A Williams, et al.
Page
of 44